Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1101)
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
233
Price
$323.25
Total Value
$75.32K
Shares Held After
20,870
% of Holdings
1.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
124
Price
$321.81
Total Value
$39.90K
Shares Held After
21,103
% of Holdings
0.6%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
10,000
Price
$3.90
Total Value
$39.00K
Shares Held After
402,702
% of Holdings
2.5%
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
148
Price
$14.90
Total Value
$2.21K
Shares Held After
154,581
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
500
Price
$326.08
Total Value
$163.04K
Shares Held After
18,693
% of Holdings
2.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
510
Price
$324.59
Total Value
$165.54K
Shares Held After
19,193
% of Holdings
2.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
740
Price
$323.55
Total Value
$239.43K
Shares Held After
19,703
% of Holdings
3.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
654
Price
$322.33
Total Value
$210.80K
Shares Held After
20,443
% of Holdings
3.1%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
15,569
Price
$19.06
Total Value
$296.75K
Shares Held After
3,517
% of Holdings
81.6%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Viswanadhan Krishnan — Chief Corp Dev & Strategy
Shares
2,959
Price
$27.80
Total Value
$82.26K
Shares Held After
5,141
% of Holdings
36.5%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
3,989
Price
$63.38
Total Value
$252.82K
Shares Held After
2,737
% of Holdings
59.3%
Metagenomi Therapeutics, Inc. (MGX)
Wapnick Pamela — Chief Financial Officer
Shares
1,581
Price
$1.60
Total Value
$2.53K
Shares Held After
187,375
% of Holdings
0.8%
Xencor Inc (XNCR)
Dahiyat Bassil I — Director
Shares
14,870
Price
$11.25
Total Value
$167.22K
Shares Held After
552,922
% of Holdings
2.6%
PTC THERAPEUTICS, INC. (PTCT)
Okey Stephanie — Director
Shares
6,333
Price
$63.38
Total Value
$401.39K
Shares Held After
8,000
% of Holdings
44.2%
Xencor Inc (XNCR)
Eckert Celia — SVP, GENERAL COUNSEL
Shares
3,244
Price
$11.25
Total Value
$36.48K
Shares Held After
78,685
% of Holdings
4.0%
Metagenomi Therapeutics, Inc. (MGX)
Irish Jian — Director
Shares
1,607
Price
$1.60
Total Value
$2.57K
Shares Held After
333,770
% of Holdings
0.5%
Xencor Inc (XNCR)
Cornelissen Bart Jan — SR. VICE PRESIDENT & CFO
Shares
2,517
Price
$11.25
Total Value
$28.30K
Shares Held After
79,397
% of Holdings
3.1%
Xencor Inc (XNCR)
Desjarlais John R — SR. VICE PRESIDENT & CSO
Shares
4,118
Price
$11.25
Total Value
$46.31K
Shares Held After
266,333
% of Holdings
1.5%
Metagenomi Therapeutics, Inc. (MGX)
Wein Matthew — Title: General Counsel, Compliance Officer and Corporate Secretary
Shares
482
Price
$1.60
Total Value
$771.20
Shares Held After
114,549
% of Holdings
0.4%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
2,014
Price
$28.93
Total Value
$58.27K
Shares Held After
169,914
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
587
Price
$487.98
Total Value
$286.45K
Shares Held After
130
% of Holdings
81.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,199
Price
$487.02
Total Value
$583.94K
Shares Held After
717
% of Holdings
62.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
798
Price
$486.20
Total Value
$387.99K
Shares Held After
1,916
% of Holdings
29.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,625
Price
$485.00
Total Value
$1.27M
Shares Held After
2,714
% of Holdings
49.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,728
Price
$484.05
Total Value
$836.44K
Shares Held After
5,339
% of Holdings
24.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,293
Price
$482.93
Total Value
$624.42K
Shares Held After
7,067
% of Holdings
15.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
510
Price
$482.05
Total Value
$245.84K
Shares Held After
8,360
% of Holdings
5.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
481
Price
$480.56
Total Value
$231.15K
Shares Held After
8,870
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
279
Price
$479.89
Total Value
$133.89K
Shares Held After
9,351
% of Holdings
2.9%
Quantum-Si Inc (QSI)
Kummeth Charles R. — Director
Shares
500,000
Price
$0.92
Total Value
$459.80K
Shares Held After
855,000
% of Holdings
58.5%
Quantum-Si Inc (QSI)
Dowdy Paula — Director
Shares
109,890
Price
$0.95
Total Value
$104.45K
Shares Held After
269,107
% of Holdings
40.8%
PTC THERAPEUTICS, INC. (PTCT)
Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Shares
10,000
Price
$63.38
Total Value
$633.80K
Shares Held After
79,944
% of Holdings
11.1%
Entera Bio Ltd. (ENTX)
Ellis Sean — Director
Shares
10,000
Price
$1.23
Total Value
$12.30K
Shares Held After
188,098
% of Holdings
5.3%
ADMA BIOLOGICS, INC. (ADMA)
ELMS STEVE — Director
Shares
7,000
Price
$15.67
Total Value
$109.69K
Shares Held After
2,038,730
% of Holdings
0.3%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
10,000
Price
$64.19
Total Value
$641.90K
Shares Held After
236,958
% of Holdings
4.0%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
104,467
Price
$30.30
Total Value
$3.17M
Shares Held After
69,302
% of Holdings
60.1%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
38,074
Price
$15.09
Total Value
$574.54K
Shares Held After
321,967
% of Holdings
10.6%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
1,786
Price
$18.74
Total Value
$33.46K
Shares Held After
339,392
% of Holdings
0.5%
Sionna Therapeutics, Inc. (SION)
Fitzpatrick Jennifer — Chief Legal Officer
Shares
10,250
Price
$33.86
Total Value
$347.02K
Shares Held After
0
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
904
Price
$14.90
Total Value
$13.47K
Shares Held After
171,606
% of Holdings
0.5%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
2,732
Price
$14.90
Total Value
$40.71K
Shares Held After
374,145
% of Holdings
0.7%
ProMIS Neurosciences Inc. (PMN)
Williams Eugene — Director
Shares
2,000
Price
$24.40
Total Value
$48.80K
Shares Held After
12,397
% of Holdings
16.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,941
Price
$16.00
Total Value
$495.06K
Shares Held After
575,235
% of Holdings
5.1%
ProMIS Neurosciences Inc. (PMN)
Williams Eugene — Director
Shares
2,000
Price
$24.00
Total Value
$48.00K
Shares Held After
10,397
% of Holdings
19.2%
FibroBiologics, Inc. (FBLG)
O'HEERON PETE — Director
Shares
15,872
Price
$0.38
Total Value
$6.01K
Shares Held After
5,958,147
% of Holdings
0.3%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
8,366
Price
$76.67
Total Value
$641.42K
Shares Held After
70,817
% of Holdings
10.6%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
10,000
Price
$4.26
Total Value
$42.56K
Shares Held After
392,702
% of Holdings
2.5%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
1,650
Price
$25.00
Total Value
$41.25K
Shares Held After
58,832
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$497.05
Total Value
$19.88K
Shares Held After
130
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$495.78
Total Value
$237.98K
Shares Held After
170
% of Holdings
73.8%
Showing 551–600 of 1101 transactions (page 12 of 23)